These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

227 related articles for article (PubMed ID: 32274730)

  • 41. The Endothelial Glycocalyx as a Key Mediator of Albumin Handling and the Development of Diabetic Nephropathy.
    Korakas E; Ikonomidis I; Markakis K; Raptis A; Dimitriadis G; Lambadiari V
    Curr Vasc Pharmacol; 2020; 18(6):619-631. PubMed ID: 31889495
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Induction of glomerular heparanase expression in rats with adriamycin nephropathy is regulated by reactive oxygen species and the renin-angiotensin system.
    Kramer A; van den Hoven M; Rops A; Wijnhoven T; van den Heuvel L; Lensen J; van Kuppevelt T; van Goor H; van der Vlag J; Navis G; Berden JH
    J Am Soc Nephrol; 2006 Sep; 17(9):2513-20. PubMed ID: 16899518
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Heparanase in inflammation and inflammation-associated cancer.
    Meirovitz A; Goldberg R; Binder A; Rubinstein AM; Hermano E; Elkin M
    FEBS J; 2013 May; 280(10):2307-19. PubMed ID: 23398975
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Heparanase is essential for the development of diabetic nephropathy in mice.
    Gil N; Goldberg R; Neuman T; Garsen M; Zcharia E; Rubinstein AM; van Kuppevelt T; Meirovitz A; Pisano C; Li JP; van der Vlag J; Vlodavsky I; Elkin M
    Diabetes; 2012 Jan; 61(1):208-16. PubMed ID: 22106160
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Alteration of endothelial proteoglycan and heparanase gene expression by high glucose, insulin and heparin.
    Han J; Hiebert LM
    Vascul Pharmacol; 2013; 59(3-4):112-8. PubMed ID: 23939434
    [TBL] [Abstract][Full Text] [Related]  

  • 46. What is the mechanism of microalbuminuria in diabetes: a role for the glomerular endothelium?
    Satchell SC; Tooke JE
    Diabetologia; 2008 May; 51(5):714-25. PubMed ID: 18347777
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Differential binding of chemokines CXCL1, CXCL2 and CCL2 to mouse glomerular endothelial cells reveals specificity for distinct heparan sulfate domains.
    van Gemst JJ; Kouwenberg M; Rops ALWMM; van Kuppevelt TH; Berden JH; Rabelink TJ; Loeven MA; van der Vlag J
    PLoS One; 2018; 13(9):e0201560. PubMed ID: 30248108
    [TBL] [Abstract][Full Text] [Related]  

  • 48. A new mechanism of action of sulodexide in diabetic nephropathy: inhibits heparanase-1 and prevents FGF-2-induced renal epithelial-mesenchymal transition.
    Masola V; Onisto M; Zaza G; Lupo A; Gambaro G
    J Transl Med; 2012 Oct; 10():213. PubMed ID: 23095131
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Glycosaminoglycans and fucoidan have a protective effect on experimental glomerulonephritis.
    Buijsers B; Maciej-Hulme M; Jacobs M; Bebber MB; de Graaf M; Salmenov R; Parr N; Rabelink TJ; Nijenhuis T; van der Vlag J
    Front Mol Biosci; 2023; 10():1223972. PubMed ID: 37475889
    [No Abstract]   [Full Text] [Related]  

  • 50. Blocking of inflammatory heparan sulfate domains by specific antibodies is not protective in experimental glomerulonephritis.
    van Gemst JJ; Passmann NJHG; Rops ALWMM; van Kuppevelt TH; Berden JH; Loeven MA; Rabelink TJ; Smeets B; van der Vlag J
    PLoS One; 2021; 16(12):e0261722. PubMed ID: 34941931
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Cinacalcet-mediated activation of the CaMKKβ-LKB1-AMPK pathway attenuates diabetic nephropathy in db/db mice by modulation of apoptosis and autophagy.
    Lim JH; Kim HW; Kim MY; Kim TW; Kim EN; Kim Y; Chung S; Kim YS; Choi BS; Kim YS; Chang YS; Kim HW; Park CW
    Cell Death Dis; 2018 Feb; 9(3):270. PubMed ID: 29449563
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Klotho attenuates renal hypertrophy and glomerular injury in Ins2Akita diabetic mice.
    Kadoya H; Satoh M; Haruna Y; Sasaki T; Kashihara N
    Clin Exp Nephrol; 2016 Oct; 20(5):671-678. PubMed ID: 26586006
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Heparanase-2 protects from LPS-mediated endothelial injury by inhibiting TLR4 signalling.
    Kiyan Y; Tkachuk S; Kurselis K; Shushakova N; Stahl K; Dawodu D; Kiyan R; Chichkov B; Haller H
    Sci Rep; 2019 Sep; 9(1):13591. PubMed ID: 31537875
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Pathobiochemical aspects of diabetic nephropathy.
    Schleicher E; Nerlich A; Gerbitz KD
    Klin Wochenschr; 1988 Sep; 66(18):873-82. PubMed ID: 2972877
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The receptor for advanced glycation endproducts mediates podocyte heparanase expression through NF-κB signaling pathway.
    An X; Zhang L; Yao Q; Li L; Wang B; Zhang J; He M; Zhang J
    Mol Cell Endocrinol; 2018 Jul; 470():14-25. PubMed ID: 28478303
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Loss of sulfated carbohydrate from the glomerular podocyte as a cause of albuminuria in experimental diabetic rats: ultrastructural histochemical study.
    Ina K; Kitamura H; Nakamura M; Ono J; Takaki R
    J Diabet Complications; 1991; 5(2-3):173-5. PubMed ID: 1770036
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Selective proteinuria in diabetic nephropathy in the rat is associated with a relative decrease in glomerular basement membrane heparan sulphate.
    van den Born J; van Kraats AA; Bakker MA; Assmann KJ; van den Heuvel LP; Veerkamp JH; Berden JH
    Diabetologia; 1995 Feb; 38(2):161-72. PubMed ID: 7713310
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Heparanase: a rainbow pharmacological target associated to multiple pathologies including rare diseases.
    Rivara S; Milazzo FM; Giannini G
    Future Med Chem; 2016 Apr; 8(6):647-80. PubMed ID: 27057774
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Effect of arctiin on glomerular filtration barrier damage in STZ-induced diabetic nephropathy rats.
    Ma ST; Liu DL; Deng JJ; Niu R; Liu RB
    Phytother Res; 2013 Oct; 27(10):1474-80. PubMed ID: 23147865
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Role of heparanase-driven inflammatory cascade in pathogenesis of diabetic nephropathy.
    Goldberg R; Rubinstein AM; Gil N; Hermano E; Li JP; van der Vlag J; Atzmon R; Meirovitz A; Elkin M
    Diabetes; 2014 Dec; 63(12):4302-13. PubMed ID: 25008182
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.